Saturday, February 10, 2018 8:02:30 PM
"There may be circumstances under which a health care provider may wish to use an unapproved device to save the life of a patient or to help a patient suffering from a serious disease or condition for which there no other alternative therapy exists. Learn more about IDEs and the expanded access requirements for medical devices.
back to top
"In some cases, patients may have to pay for using the investigational drug and/or for medical care associated with the use of the investigational drug. In others, pharmaceutical companies may elect not to charge.
https://www.fda.gov/NewsEvents/PublicHealthFocus/ExpandedAccessCompassionateUse/default.htm#Expanded_Access_to_Investigational_Medical_Devices
https://www.fda.gov/NewsEvents/PublicHealthFocus/ExpandedAccessCompassionateUse/default.htm
*****************
We provide information and access to treatment options within Clinical Trials & Early Access Programs
"myTomorrows"
https://mytomorrows.com/en/?utm_campaign=AW_EMEAU_ENG_Brand_Desktop_Hygiene_22.01.18_BR01WWENGV2_BMM&utm_source=google&utm_medium=cpc&utm_term=%2Bcompassionate%20%2Buse&utm_content=EMEAU_ENG_HY_TextAd5V4&utm_id=787118616&gclid=EAIaIQobChMIrNn7icic2QIViz2BCh2mVAPqEAAYASAAEgLib_D_BwE
***************
FDA Simplifies Compassionate Use Application and Drug Costs
https://www.medscape.com/viewarticle/864310
******************
Practical, Legal, and Ethical Issues in Expanded Access to Investigational Drugs
http://www.nejm.org/doi/full/10.1056/NEJMhle1409465
*************************
Working Group on Compassionate Use and Pre-Approval Access
https://med.nyu.edu/pophealth/divisions/medical-ethics/compassionate-use
****************************
Compassionate Drug Use - American Cancer Society (speaking CAR-T cancer therapy)
" Some drug companies will supply the drug for free, but others charge patients. Most insurance companies will not pay for investigational drugs. There may also be ...
https://www.cancer.org/treatment/treatments-and-side-effects/clinical-trials/compassionate-drug-use.html
**************************************
An overview of Compassionate Use Programs in the European Union member states
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5116859/
Recent MESO News
- Appendix 4c Quarterly Activity Report for Quarter Ended March 31, 2024 • GlobeNewswire Inc. • 04/30/2024 01:05:17 AM
- FDA Commentary Sends Biotech Soaring During Premarket Hours • AllPennyStocks.com • 03/26/2024 01:25:00 PM
- United States Food & Drug Administration (FDA) Notifies Mesoblast that Available Clinical Data from Phase 3 Trial Appear Sufficient to Support BLA Submission for Remestemcel-L in Children with Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD) • GlobeNewswire Inc. • 03/26/2024 02:34:20 AM
- Mesoblast Successfully Completes Placement and Accelerated Entitlement Offer • GlobeNewswire Inc. • 03/13/2024 11:30:47 PM
- United States Food & Drug Administration (FDA) Supports Accelerated Approval Pathway for Rexlemestrocel-L in End-Stage Heart Failure Patients with a Left Ventricular Assist Device (LVAD) • GlobeNewswire Inc. • 03/10/2024 11:54:12 PM
- Mesoblast Reports Financial Results and Operational Update for Half-Year Ended December 31, 2023 • GlobeNewswire Inc. • 02/28/2024 10:57:09 PM
- Mesoblast Financial Results and Corporate Update Webcast • GlobeNewswire Inc. • 02/26/2024 12:00:00 PM
- United States Food & Drug Administration (FDA) Grants Mesoblast Orphan-Drug Designation for Revascor® (Rexlemestrocel-L) in Children With Congenital Heart Disease • GlobeNewswire Inc. • 02/15/2024 12:46:40 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/01/2024 02:34:30 AM
- Appendix 4C Quarterly Activity Report for Quarter Ended December 31, 2023 • GlobeNewswire Inc. • 01/31/2024 02:13:34 AM
- Mesoblast Gets FDA's Special Pediatric Designation for Revascor Heart Treatment • Dow Jones News • 01/19/2024 12:28:00 AM
- United States Food & Drug Administration (FDA) Grants Mesoblast Rare Pediatric Disease Designation for Revascor® (Rexlemestrocel-L) in Children With Congenital Heart Disease • GlobeNewswire Inc. • 01/18/2024 11:36:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/16/2024 11:33:54 AM
- Form F-6 POS - Post-effective amendments for immediately effective filing • Edgar (US Regulatory) • 01/05/2024 02:57:09 AM
- Form F-6 POS - Post-effective amendments for immediately effective filing • Edgar (US Regulatory) • 12/22/2023 10:13:02 PM
- Mesoblast Files for Orphan Drug and Pediatric Rare Disease Designations for Rexlemestrocel-L as Treatment for Severe Congenital Heart Disease • GlobeNewswire Inc. • 11/26/2023 11:56:21 PM
- Biotech Shares Soar Following Major Announcement • AllPennyStocks.com • 11/22/2023 06:35:00 PM
- Biotech Shares Soar Following Major Announcement • AllPennyStocks.com • 11/22/2023 06:35:00 PM
- Mesoblast Partners With Blood and Marrow Transplant Clinical Trials Network (BMT CTN) on Pivotal Trial in Adults With SR-aGVHD • GlobeNewswire Inc. • 11/21/2023 11:32:27 PM
- Appendix 4C Quarterly Activity Report for Quarter Ended September 30, 2023 • GlobeNewswire Inc. • 10/31/2023 12:04:17 AM
- Jane Bell AM Appointed Chair of Mesoblast Audit and Risk Committee • GlobeNewswire Inc. • 09/26/2023 10:18:49 AM
- Key Outcomes From FDA Type A Meeting and Mesoblast Next Steps to Achieve RYONCIL Approval • GlobeNewswire Inc. • 09/21/2023 07:30:42 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 09/06/2023 10:42:49 AM
- Mesoblast Reports Financial Results and Operational Update for Fiscal Year Ended June 30, 2023 • GlobeNewswire Inc. • 08/30/2023 11:07:02 PM
- Mesoblast Financial Results and Corporate Update Webcast • GlobeNewswire Inc. • 08/29/2023 11:00:00 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM